Page last updated: 2024-08-26

uftoral and Bile Duct Cancer

uftoral has been researched along with Bile Duct Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirano, T; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Mori, M; Shimonishi, T1
Hioki, M; Hirano, S; Hirata, T; Hisayoshi, T; Kutsukata, N; Masuda, S; Yamagishi, S; Yamamoto, S; Yamashita, Y1

Other Studies

2 other study(ies) available for uftoral and Bile Duct Cancer

ArticleYear
[A case of liver metastatic recurrence of bile duct cancer completely responding to single drug, UFT, chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Duct Neoplasms; Common Bile Duct; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Male; Radiotherapy, High-Energy; Remission Induction; Tegafur; Uracil

2004
[A case of far-advanced gastric cancer treated with neoadjuvant combination chemotherapy of UFT, low-dose CDDP and leucovorin, followed by subtotal gastrectomy with curative intent].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Leucovorin; Male; Neoplasm Invasiveness; Portal Vein; Stomach Neoplasms; Tegafur; Uracil

1997